3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
6
Neoplasm Metastasis
3
Prostatic Neoplasms
1
Pain
1
Interventions
Docetaxel
17
Surveys and Questionnaires
15
pembrolizumab
14
Specimen Handling
10
Radiotherapy
10
Early Intervention, Educational
10
Zoledronic Acid
9
Interviews as Topic
9
olaparib
8
Standard of Care
8
Psychiatric Rehabilitation
8
Therapeutics
7
Magnetic Resonance Spectroscopy
7
Gemcitabine
7
Fulvestrant
7
durvalumab
6
Paclitaxel
6
Nivolumab
6
Methods
6
Educational Status
6
Carboplatin
6
enzalutamide
5
Trastuzumab
5
Radiosurgery
5
Exercise
5
Cyclophosphamide
5
palbociclib
4
Taxes
4
Sirolimus
4
Letrozole
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Pamidronate
×
Breast
×
Clear all
NCT02721433
2020-12-02
REaCT-BTA
Ottawa Hospital Research Institute
Phase 4
Completed
263 enrolled